|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 22/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 30/09/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 31/03/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/12/2014 | |
Haruhisa Inada
BRD | Director/Board Member | - | 29/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 30/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.05% | +0.46% | -12.50% | -28.55% | 240B | ||
| +0.06% | -1.43% | -44.95% | -55.73% | 41.07B | ||
| -0.38% | -3.20% | -43.28% | -49.47% | 21.13B | ||
| -0.91% | -2.18% | -39.04% | -63.42% | 17.94B | ||
| -0.67% | -0.75% | +16.10% | +51.20% | 11.32B | ||
| +0.97% | -0.55% | -46.91% | -70.87% | 8.71B | ||
| -1.79% | -0.07% | -10.39% | -51.01% | 8.15B | ||
| +0.23% | -5.65% | -47.84% | -66.42% | 6.46B | ||
| +0.14% | -7.51% | -37.20% | -53.53% | 5.29B | ||
| Average | -0.26% | -1.03% | -29.56% | -43.09% | 40.05B | |
| Weighted average by Cap. | -0.12% | -0.49% | -20.21% | -34.68% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















